A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer
- Martin, M.
- Bonneterre, J.
- Geyer Jr., C.E.
- Ito, Y.
- Ro, J.
- Lang, I.
- Kim, S.-B.
- Germa, C.
- Vermette, J.
- Wang, K.
- Wang, K.
- Awada, A.
ISSN: 0959-8049, 1879-0852
Year of publication: 2013
Volume: 49
Issue: 18
Pages: 3763-3772
Type: Article